Description: Theralase Technologies Inc. designs, manufactures and markets patented, superpulsed laser technology used in healing injured tissue and destroying cancer. Theralase technology is safe and effective in eliminating pain, reducing inflammation and accelerating tissue regeneration of numerous nerve, muscle and joint injuries. Theralase is actively developing patented technology that is able to target and destroy cancers, bacteria and viruses when light activated.
Home Page: www.theralase.com
41 Hollinger Road
Toronto,
ON
M4B 3G4
Canada
Phone:
416 699 5273
Officers
| Name | Title |
|---|---|
| Dr. Arkady Mandel DSc., M.D., Ph.D. | Interim CEO, Chief Scientific Officer & Director |
| Ms. Kristina Hachey CPA | CFO & Director |
| Mr. David M. Groves B.A | Pres of World Trade Division |
| Mr. Roger John Dumoulin-White | Director of Bus. Devel. |
| Lori Leach | Marketing & Media Relations Consultant |
| Mr. Vaughn Wyant | Marketing & Media Relations Consultant |
| Dr. Terry Ruch DVM | Equine Medical Consultant |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 20.0096 |
| Price-to-Sales TTM: | 52.9225 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |